INTRODUCTION: Bariatric surgery treats morbid obesity resulting in long-lasting weight loss. Elevated body mass index (BMI) increases breast cancer risk. We hypothesized that patients undergoing bariatric surgery would have decreased overall and estrogen receptor (ER)-positive breast cancer incidences compared to a propensity-matched non-surgical cohort. METHODS: The bariatric population included all female patients who underwent weight loss surgery at a single institution from 1985 to 2015. Patients from all outpatient visits were propensity score matched 1:1 with bariatric patients using BMI, comorbidities, demographics, and insurance status. The primary outcome was breast cancer incidence. Univariate analyses compared the groups. RESULTS: A total of 4860 patients were included, with 2430 in both groups. Median follow-up time from date of surgery or morbid obesity diagnosis was 5.7 years. There were no differences in age or comorbidities aside from gastroesophageal reflux disease. Seventeen (0.7%) patients in the surgery group were subsequently diagnosed with breast cancer versus 32 (1.3%) in the non-surgery group (p = 0.03). The non-surgery group had more ER-positive tumors [4 (36.4%) vs. 22 (71.0%); p = 0.04]. CONCLUSION: Female patients who underwent bariatric surgery were less frequently diagnosed with any breast cancer and ER-positive breast cancer versus a propensity-matched cohort suggesting a possible oncologic benefit to weight loss surgery.
INTRODUCTION: Bariatric surgery treats morbid obesity resulting in long-lasting weight loss. Elevated body mass index (BMI) increases breast cancer risk. We hypothesized that patients undergoing bariatric surgery would have decreased overall and estrogen receptor (ER)-positive breast cancer incidences compared to a propensity-matched non-surgical cohort. METHODS: The bariatric population included all female patients who underwent weight loss surgery at a single institution from 1985 to 2015. Patients from all outpatient visits were propensity score matched 1:1 with bariatric patients using BMI, comorbidities, demographics, and insurance status. The primary outcome was breast cancer incidence. Univariate analyses compared the groups. RESULTS: A total of 4860 patients were included, with 2430 in both groups. Median follow-up time from date of surgery or morbid obesity diagnosis was 5.7 years. There were no differences in age or comorbidities aside from gastroesophageal reflux disease. Seventeen (0.7%) patients in the surgery group were subsequently diagnosed with breast cancer versus 32 (1.3%) in the non-surgery group (p = 0.03). The non-surgery group had more ER-positive tumors [4 (36.4%) vs. 22 (71.0%); p = 0.04]. CONCLUSION: Female patients who underwent bariatric surgery were less frequently diagnosed with any breast cancer and ER-positive breast cancer versus a propensity-matched cohort suggesting a possible oncologic benefit to weight loss surgery.
Entities:
Keywords:
Cancer risk; Morbid obesity; Weight loss surgery
Authors: J Hunter Mehaffey; Mathew G Mullen; Rachel L Mehaffey; Florence E Turrentine; Steven K Malin; Jennifer L Kirby; Bruce Schirmer; Peter T Hallowell Journal: Surg Endosc Date: 2016-05-13 Impact factor: 4.584
Authors: Béatrice Lauby-Secretan; Chiara Scoccianti; Dana Loomis; Yann Grosse; Franca Bianchini; Kurt Straif Journal: N Engl J Med Date: 2016-08-25 Impact factor: 91.245
Authors: Irene D Bezemer; Sabina Rinaldi; Laure Dossus; Carla H van Gils; Petra H M Peeters; Paulus A H van Noord; H Bas Bueno-de-Mesquita; Soren Paaske Johnsen; Kim Overvad; Anja Olsen; Anne Tjønneland; Heiner Boeing; Petra H Lahmann; Jakob Linseisen; Gabriele Nagel; Naomi Allen; Andrew Roddam; Sheila Bingham; Kay-Tee Khaw; Emmanuelle Kesse; Bertrand Téhard; Françoise Clavel-Chapelon; Antonio Agudo; Eva Ardanaz; J R Quiros; Pilar Amiano; C Martínez-Garcia; M J Tormo; Valeria Pala; Salvatore Panico; Paolo Vineis; Domenico Palli; Rosario Tumino; Antonia Trichopoulou; N Baibas; D Zilis; Bertrand Hémon; Teresa Norat; Elio Riboli; Rudolf Kaaks Journal: Cancer Causes Control Date: 2005-06 Impact factor: 2.506
Authors: Susan C Modesitt; Peter T Hallowell; Jill K Slack-Davis; Ryan D Michalek; Kristen A Atkins; Sarah L Kelley; Sanja Arapovic; Margaret A Shupnik; Kyle Hoehn Journal: Gynecol Oncol Date: 2015-05-23 Impact factor: 5.482
Authors: Michael C S Bissell; Karla Kerlikowske; Brian L Sprague; Jeffery A Tice; Charlotte C Gard; Katherine Y Tossas; Garth H Rauscher; Amy Trentham-Dietz; Louise M Henderson; Tracy Onega; Theresa H M Keegan; Diana L Miglioretti Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-07-29 Impact factor: 4.254